Latest Benvenue Medical Inc. Stories
SANTA CLARA, Calif., May 21, 2013 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced it has completed the 12-month patient follow-up phase in the KAST (Kiva System as a Vertebral Augmentation Treatment - A Safety and Effectiveness Trial) clinical trial. KAST is being conducted to support a 510(k) application for market clearance from the U.S. Food and Drug Administration (FDA), which Benvenue Medical expects to submit in...
Published in Techniques in Regional Anesthesia and Pain Management, Review Article Discusses Emerging VCF Treatments and Technologies SANTA CLARA, Calif., April 22, 2013 /PRNewswire/ -- In a review of minimally invasive, state-of-the-art treatments for vertebral compression fractures (VCFs), the Kiva VCF Treatment System and the Blazer Vertebral Augmentation System, both by Benvenue Medical, Inc., were highlighted among the most innovative experimental and commercial technologies...
Published in Pain Physician Journal, Study Also Concludes Implant Design May Reduce Extravasation vs. Vertebroplasty and Kyphoplasty SANTA CLARA, Calif., March 18, 2013 /PRNewswire/ -- A physician-driven prospective study of patients with painful osteolytic vertebral metastases treated with the Kiva VCF Treatment System by Benvenue Medical, Inc. found all patients experienced a clinically relevant improvement in pain and statistically significant functional improvement. The...
SANTA CLARA, Calif., Feb. 19, 2013 /PRNewswire/ -- An independent, prospective, randomized study of patients with vertebral compression fractures (VCFs) comparing the effectiveness of balloon kyphoplasty with the Kiva VCF Treatment System by Benvenue Medical, Inc. found that only the Kiva system significantly restored vertebral body wedge deformity, Gardner angle. The Kiva system also resulted in significantly lower rates of extravasation and cement volume than balloon kyphoplasty....
SANTA CLARA, Calif., July 31, 2012 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced it has met the pre-determined stopping rules for enrollment completion in the KAST (Kiva System as a Vertebral Augmentation Treatment - A Safety and Effectiveness Trial) clinical trial. (Logo: http://photos.prnewswire.com/prnh/20110418/SF84532LOGO) The KAST trial enrolled 300 patients and is being conducted to support a subsequent...
SANTA CLARA, Calif., June 28, 2012 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced it completed a $25 million Series D round of financing. The spine company intends to use the proceeds to sustain global commercialization of its three breakthrough minimally invasive products to treat degenerative disc disease (DDD) with spinal fusion and vertebral compression fractures (VCFs), as well as for additional initiatives...
SANTA CLARA, Calif., May 21, 2012 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced today the appointments of two new members to its Board of Directors. Thomas M. Prescott, president and CEO of Align Technology, Inc., and Thomas C. Wilder, president and CEO of Sequent Medical, Inc., are both experienced at bringing innovative medical technologies to the global marketplace. (Logo:...
SANTA CLARA, Calif., March 27, 2012 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced today over 250 patients have been enrolled in the landmark KAST (Kiva System as a Vertebral Augmentation Treatment - A Safety and Effectiveness Trial) clinical trial. KAST is evaluating Benvenue Medical's Kiva VCF Treatment System in the largest randomized study to date versus the current standard of care, balloon kyphoplasty, in...
SAN FRANCISCO, March 26, 2012 /PRNewswire/ -- Today Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, launched the Blazer Vertebral Augmentation System for vertebral compression fractures (VCF) in the U.S. at the 2012 Society of Interventional Radiology (SIR) annual meeting. Blazer is the first clinical product in Benvenue Medical's portfolio to be commercially available in the U.S., and it is designed for spine specialists to mechanically create...
SANTA CLARA, Calif., March 20, 2012 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced that it has actively started enrolling patients in the Luna Interbody System for Fusion Trial (LIFT). Eleven (11) patients have already enrolled at two sites (Bonn and Zwickau) in Germany. LIFT is a European post-market, multi-center, prospective, non-randomized single-arm study aimed at collecting clinical data on the effectiveness of...
